COSCIENS Biopharma Inc. (CSCIF) Free cash flow 2016–2025
COSCIENS Biopharma Inc. (CSCIF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.2MFY2025 · since FY2016: -$29.1M → -$9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.2M | +41.6% |
| FY2024 | -$15.7M | -376.1% |
| FY2023 | -$3.3M | -167.1% |
| FY2022 | $4.9M | +157.2% |
| FY2021 | -$8.6M | — |
| FY2018 | $6.8M | +129.7% |
| FY2017 | -$22.9M | +21.2% |
| FY2016 | -$29.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice